Maria D. Korochkina

Ms. Maria D. Korochkina

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RTRoman P. Terekhov
Roman P. Terekhov
ASArtem Aleksandrovich Svotin
Artem Aleksandrovich Svotin
Denis Igorevich PankovDenis Igorevich Pankov
Denis Igorevich Pankov
MKMaria D. Korochkina
Maria D. Korochkina
EKElizaveta A. Krivosheeva
Elizaveta A. Krivosheeva
ISIrina Selivanova
Irina Selivanova
Background: Obesity is a global epidemic and a complex chronic disease affecting more than one billion patients, leading to severe health issues like diabetes, heart disease, and cancer. While lifestyle changes are the first-line treatment, they are often insufficient. Current medications may cause severe side effects, including muscle loss and vision problems. Objectives: This systematic review aims to generalize and evaluate data from preclinical studies on the effect of flavonoid dihydroquercetin (DHQ) on weight loss in experimental animals compared with placebo-treated animals. Methods: This systematic review was conducted in accordance with the PRISMA guidelines. The protocol was registered in the PROSPERO database in August 2025 (CRD420251129793). Risk of bias (RoB) was assessed by using SYRCLE’s tool. Results: In total, eight studies included in the systematic review involved 175 animals (14 treatment groups and 9 control groups). Calculation of correlations between the reported effect on weight change and initial weight showed a strong association between these rates (R −0.9883). The intensity of DHQ effect depended on the condition: There were strong negative correlations between DHQ dose and the observed effect in diabetes mellitus (R −0.9056), hepatic lipid dysmetabolism (R −0.9339), and hepatic fibrosis (R −0.9025) in mice and rats’ data together. Conclusions: Intake of DHQ in the course of one month and three months resulted in a decrease in animals’ weight by 5.24% ± 1.95% and 18.29% ± 1.96% (p < 0.0001), respectively. Taken together, our results suggest the rationality for further research of DHQ as an anorexigenic agent, focusing on the stereochemistry of this flavonoid and its bioavailability optimization.

Verified
Journal Article
Open access
PDF file
RTRoman P. Terekhov
Roman P. Terekhov
ATAmir Taldaev
Amir Taldaev
ASArtem Aleksandrovich Svotin
Artem Aleksandrovich Svotin
Denis Igorevich PankovDenis Igorevich Pankov
Denis Igorevich Pankov
ESEvgenia Sukhova
Evgenia Sukhova
ISIrina Selivanova
Irina Selivanova
Dihydroquercetin (DHQ) is a promising object for the development of a treatment for patients with obesity and prediabetes requiring a moderate therapeutic effect. This paper reports a clinical case of DHQ application in a 30-year-old Caucasian male and proposes a molecular mechanism of its anti-obesity effect. DHQ was administrated as a dietary supplement at a dose of 100–200 mg/day during 3 months with treatment interruption for 1 month. The data collected one month before the treatment were used as a control. The molecular aspects were studied via molecular docking with β3-adrenoceptor (ADRB3, PDB ID: 9IJE) and peroxisome proliferator-activated receptor γ (PPARG, PDB ID: 2ZNO) and molecular dynamic simulation under conditions mimicking a human cellular environment. A pronounced weight decrease up to 0.73 kg/week was observed during DHQ administration. The highest affinity to ADRB3 was observed for the non-ionized H2aH3e-conformation of 2S,3R-DHQ (–8.846 kcal/mol). Molecules with 2S-configuration demonstrate 0.332 kcal/mol higher affinity to PPARG compared to 2R-stereoisomers. The intermolecular complex with cis-DHQ demonstrated higher stability in molecular dynamics simulation. The insights gained from this study may contribute to our understanding of flavonoids not merely as antioxidants but also as active ingredients that selectively interact with receptors. If future investigations confirm these results, they may serve as a foundation for developing a new class of anti-obesity remedies that act via ADRB3.

20 April 2026 in Problems of Biological, Medical and Pharmaceutical Chemistry
Verified
Journal Article
Closed access
RTRoman P. Terekhov
Roman P. Terekhov
ASArtem Aleksandrovich Svotin
Artem Aleksandrovich Svotin
Denis Igorevich PankovDenis Igorevich Pankov
Denis Igorevich Pankov
MKMaria D. Korochkina
Maria D. Korochkina
EKE. Krivosheeva
E. Krivosheeva
ISIrina Selivanova
Irina Selivanova
Obesity is a distinct disease that leads to severe health issues like diabetes, heart disease, and cancer. The spread of this pathology can be compared to an epidemic. The search for medications for weight control remains an actual challenge for pharmaceutical and medical sciences. In particular, studying the anorexigenic effect of the flavanol dihydroquercetin (DHQ) is of special interest. Bibliographic databases contain a lot of studies reporting the dynamics of weight changes on the background of taking this flavonoid, and recent studies have shown that DHQ promotes weight loss. Therefore, the aim of this article is to assess the data of experimental studies on the effect of DHQ on the body weight of experimental animal model compared to control groups. The study results demonstrate statistically significant weight loss in mice and rats with various pathologies within the first month of DHQ administration. The biological effect of the flavonoid under the described conditions was comparable to the effect of GLP-1 receptor agonists. Thus, if the results of fundamental research are successfully translated into clinical practice, the use of this flavonoid will make it possible to reduce therapeutic doses of standard medications and will provide administration for patients requiring mild pharmacological intervention. This could improve the life quality of 483 million patients worldwide. Realization of this strategy would reduce the procurement and production of GLP-1 receptor agonists, which, given the high cost of treatment, would reduce the economic burden on the healthcare system. A systematic review identified a number of challenges for pharmaceutical science that require solutions for the successful development of a drug based on DHQ. In particular, future research should focus on studying the influence of flavanonol stereochemistry on its biological effect, as well as on identifying modifications with improved bio-availability and optimal dosage form.

9 July 2026 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
RTRoman P. Terekhov
Roman P. Terekhov
MKMaria D. Korochkina
Maria D. Korochkina
ЕКЕлизавета Кривозубова
Елизавета Кривозубова
GEGrigory Yu. Evzikov
Grigory Yu. Evzikov
ASArtem Aleksandrovich Svotin
Artem Aleksandrovich Svotin
ISIrina Selivanova
Irina Selivanova
Oral diseases cause a wide range of difficulties for patients. The natural bioactive compound dihydroquercetin (DHQ), which demonstrates regenerative, anti-inflammatory, antioxidative, and antibacterial effects, is of interest for their treatment. The combination of DHQ and l-lysine DHQ is “very easily soluble”. The aim of this study is to compare orally disintegrating tablets based on raw DHQ and on the DHQ-l-lysine composition. Following the guidelines outlined in the ICH Q8 (R2) standard, a fundamental quality target product profile and critical quality attributes were established. The Sediment Delivery Model (SeDeM) method was used to evaluate the substance suitability for direct compression. Quantitative analysis of the DHQ release was carried out by high-performance liquid chromatography, and infrared (IR) spectroscopy was performed using the attenuated total reflection technique without any prior sample preparation. The DHQ-l-lysine composition shows improved dimensions (4.12) and flowability (4.96). The release rate constants (Krelease) were 8.14 and 3.61%/min, while the half-release periods (t50%) were 6.14 and 13.85 min for tablets with DHQ (TF1) and DHQ-l-lysine compositions (TF2), respectively. The difference factor (f1) and similarity factor (f2) were 23.43% and 43.37%, respectively. The tablet manufacture had a critical impact on the characteristics of the IR spectra (the r values −0.8785 and 0.5474 for TF1 and TF2). The conducted study demonstrates the promise of using DHQ-l-lysine composition for developing effective dosage forms with improved technological characteristics and controlled release of the active substance.

2 March 2026 in Drug development & registration
Verified
Journal Article
Open access
PDF file
RTRoman P. Terekhov
Roman P. Terekhov
III. R. Ilyasov
I. R. Ilyasov
BLBo LI
Bo LI
YZY. Zeng
Y. Zeng
Denis Igorevich PankovDenis Igorevich Pankov
Denis Igorevich Pankov
ISIrina Selivanova
Irina Selivanova
Introduction. Flavanonol dihydroquercetin (DHQ) is known for its pronounced antioxidant properties, which are associated with a wide range of biological activity of this compound. Due to the presence of two chiral centers at positions 2 and 3 of the benzopyranone ring, this flavonoid is characterized by the phenomenon of cis-trans isomerism. However, a comparative analysis of the antioxidant properties of DHQ diastereomers has not been performed before. Aim. To evaluate the effect of diastereomeric composition on the reducing and radical scavenging properties of DHQ samples. Materials and methods. The diastereomeric composition of the DHQ samples was controlled under reverse phase chromatography with UV detection. The antioxidant capacity was studied using a model of inhibition of radical cations of 2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS +• ). The reducing ability of the DHQ samples was evaluated using a 5-(2,4-disulfophenyl)-3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-2 H -tetrazolium monosodium salt (WST-8) model. Both tests were performed under the control of UV spectrophotometry. Results and discussion. The chromatograms of the samples obtained at 288 nm are characterized by two peaks with retention times of 18.79 ± 0.08 and 19.87 ± 0.08 min, which correspond to trans - and cis -diastereomers of DHQ. After 6 minutes of DHQ samples containing 0.8, 3.7, and 9.5 % of the cis-isomer adding to the ABTS •+ solution, the optical density at 730 nm decreased by 0.588 ± 0.008, 0.581 ± 0.017, and 0.602 ± 0.012, respectively (α 0.05, p 0.2196, r 0.7857), while in WST-8 solutions at 450 nm for similar samples, an increase in optical density was observed by 0.178 ± 0.030, 0.222 ± 0.026, and 0.188 ± 0.036, respectively (α 0.05, p 0.5157, r 0.0284). Conclusion. These results indicate that there is no significant effect of the diastereomeric composition on the antioxidant properties of the DHQ samples. Thus, the observed differences in the pharmacology of cis - and trans -DHQ should be explained by the selectivity of interaction with biological targets, rather than the free radicals scavenging activity.

27 November 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ASArtem Aleksandrovich Svotin
Artem Aleksandrovich Svotin
MKMaria D. Korochkina
Maria D. Korochkina
AKAnastasia Khodyachikh
Anastasia Khodyachikh
DKDiana R. Kolesnikova
Diana R. Kolesnikova
ATAmir Taldaev
Amir Taldaev
ISIrina Selivanova
Irina Selivanova
Background/Objectives: Dihydroquercetin (DHQ), also known as taxifolin, is a natural flavonoid which has anti-inflammatory and wound-healing biological effects. One of the main limitations for developing formulations with DHQ is its low solubility in water at room temperature. One of the high-potential co-formers for increasing its solubility is l-lysine, which has an aliphatic amino group in the side radical capable of entering into intermolecular interactions with the phenolic hydroxyl groups of DHQ. Methods: Several modifications were obtained using grinding, drying, and lyophilization methods. Subsequent evaluation was conducted using a combination of physicochemical and biological analytical methods. Results: Obtained modifications could be described as very easily soluble substances. The absence of the formation of new covalent bonds between the compounds during the formation of such systems was established. The glass transition effect was detected at 64 °C for the obtained films. It is important to note that as a result of studying the cytotoxic properties of the objects, a decrease in cytotoxicity was established during lyophilization of the mechanical mixture of the initial components. For these lyophilizates, the IC50 value was 0.025 mg/mL, 0.068 mg/mL, 0.145 mg/mL, and 0.288 mg/mL for the 3T3, HEK293, Caco-2, and HUVEC cell lines, respectively. Conclusions: Co-amorphous systems of DHQ and l-lysine in the form of films and lyophilizates were obtained and described. These objects may be interesting from the point of view of increasing the solubility of natural flavonoids, which solves one of the main problems in developing drugs based on them.